Sofosbuvir + velpatasvir

Janessa M. Smith, PharmD, BCPS

INDICATIONS

FDA

Treatment of adult patients with chronic HCV genotype 1, 2, 3, 4, 5 or 6 without cirrhosis or with compensated cirrhosis or with decompensated cirrhosis in combination with ribavirin

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: July 27, 2020